A phase I dose escalation study of cisplatin, pemetrexed and radiotherapy for inoperable stage III non-small cell lung cancer.
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2011
At a glance
- Drugs Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 05 Nov 2009 Additional trial identifiers (NTR752, 2208) identified as reported by Netherlands Trial Register.
- 25 Apr 2007 New trial record.